openPR Logo
Press release

Immunology Drug Market Size, Growth and Forecast 2021 to 2028 By Ameco Research

08-26-2021 08:48 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Ameco Research

The worldwide Immunology Drug market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner rather than later.

DOWNLOAD FREE SAMPLE STUDY PDF (INCLUDING FULL TOC, TABLE & FIGURES) @ https://www.amecoresearch.com/sample/271234

The Immunology Drug market is finely sectioned by thinking about the most significant and responsive parts of the individual market. Furthermore, the fragments are all around examined for each topographical district including United States, European Union, China, Japan, India, Korea, and Southeast Asia. The significant nations are covered with nitty gritty data.

In particular, the effect of the COVID-19 pandemic that has disturbed the worldwide market as far as the production network, cash stream, and generally market financial matters is completely covered by remembering subjective and quantitative methodologies for the last report.

Aside from the division, the statistical surveying report includes set up essential devices (Value Chain Analysis, Supply Channel Analysis, Porter's five powers model, and others) that help people in simple arrangement and dissecting the general data in a more thorough and precise way.

BY TYPE & BY COMPANY:
By the product type, the market is primarily split into
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication

By the end users/application, this report covers the following segments
Hospitals
Clinics
Cancer Research Centers and Institutes

Competitive Landscape:
The report provides a list of all the key players in the Immunology Drug market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.

The Immunology Drug key manufacturers in this market include:
Abbott Laboratories
Active Biotech
Eli Lilly and Company
Autoimmune Inc.
Pfizer
GlaxoSmithKline plc
Seattle Genetics
Genentech
F. Hoffmann-La Roche Ltd.
Eisai Co.
Bayer AG
Sanofi Aventis LLC.

CUSTOMIZED REQUIREMENTS? NEED ANY HELP? PLEASE EMAIL US AT@ sales@amecoresearch.com

The greater part of the top significant players are being shrouded in the examination report alongside their item contributions, income commitment, provincial presence, key turns of events, and business strength.

Report Link @ https://www.amecoresearch.com/market-report/global-immunology-drug-market-2021-2028-271234

TABLE OF CONTENT:
1 Immunology Drug Market Overview
1.1 Immunology Drug Product Overview
1.2 Immunology Drug Market Segment by Type
1.2.1 Monoclonal Antibodies (mAb)
1.2.2 Antibody Drug Conjugates
1.2.3 Interferon and Cytokine therapies
1.2.4 Immunosuppressive medication
1.3 Global Immunology Drug Market Size by Type
1.3.1 Global Immunology Drug Market Size Overview by Type (2016-2027)
1.3.2 Global Immunology Drug Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Immunology Drug Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Immunology Drug Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Immunology Drug Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Immunology Drug Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Immunology Drug Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Immunology Drug Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Immunology Drug Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Immunology Drug Sales Breakdown by Type (2016-2021)
1.4.2 Europe Immunology Drug Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Immunology Drug Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Immunology Drug Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Immunology Drug Sales Breakdown by Type (2016-2021)

2 Global Immunology Drug Market Competition by Company
2.1 Global Top Players by Immunology Drug Sales (2016-2021)
2.2 Global Top Players by Immunology Drug Revenue (2016-2021)
2.3 Global Top Players Immunology Drug Price (2016-2021)
2.4 Global Top Manufacturers Immunology Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Immunology Drug Market Competitive Situation and Trends
2.5.1 Immunology Drug Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Immunology Drug Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Immunology Drug as of 2020)
2.7 Date of Key Manufacturers Enter into Immunology Drug Market
2.8 Key Manufacturers Immunology Drug Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Immunology Drug Status and Outlook by Region
3.1 Global Immunology Drug Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Immunology Drug Historic Market Size by Region
3.2.1 Global Immunology Drug Sales in Volume by Region (2016-2021)
3.2.2 Global Immunology Drug Sales in Value by Region (2016-2021)
3.2.3 Global Immunology Drug Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Immunology Drug Forecasted Market Size by Region
3.3.1 Global Immunology Drug Sales in Volume by Region (2022-2027)
3.3.2 Global Immunology Drug Sales in Value by Region (2022-2027)
3.3.3 Global Immunology Drug Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Immunology Drug by Application
4.1 Immunology Drug Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Cancer Research Centers and Institutes
4.2 Global Immunology Drug Market Size by Application
4.2.1 Global Immunology Drug Market Size Overview by Application (2016-2027)
4.2.2 Global Immunology Drug Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Immunology Drug Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Immunology Drug Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Immunology Drug Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Immunology Drug Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Immunology Drug Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Immunology Drug Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Immunology Drug Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Immunology Drug Sales Breakdown by Application (2016-2021)
4.3.2 Europe Immunology Drug Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Immunology Drug Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Immunology Drug Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Immunology Drug Sales Breakdown by Application (2016-2021)

5 North America Immunology Drug by Country
5.1 North America Immunology Drug Historic Market Size by Country
5.1.1 North America Immunology Drug Sales in Volume by Country (2016-2021)
5.1.2 North America Immunology Drug Sales in Value by Country (2016-2021)
5.2 North America Immunology Drug Forecasted Market Size by Country
5.2.1 North America Immunology Drug Sales in Volume by Country (2022-2027)
5.2.2 North America Immunology Drug Sales in Value by Country (2022-2027)

6 Europe Immunology Drug by Country
6.1 Europe Immunology Drug Historic Market Size by Country
6.1.1 Europe Immunology Drug Sales in Volume by Country (2016-2021)
6.1.2 Europe Immunology Drug Sales in Value by Country (2016-2021)
6.2 Europe Immunology Drug Forecasted Market Size by Country
6.2.1 Europe Immunology Drug Sales in Volume by Country (2022-2027)
6.2.2 Europe Immunology Drug Sales in Value by Country (2022-2027)

7 Asia-Pacific Immunology Drug by Region
7.1 Asia-Pacific Immunology Drug Historic Market Size by Region
7.1.1 Asia-Pacific Immunology Drug Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Immunology Drug Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Immunology Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Immunology Drug Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Immunology Drug Sales in Value by Region (2022-2027)

8 Latin America Immunology Drug by Country
8.1 Latin America Immunology Drug Historic Market Size by Country
8.1.1 Latin America Immunology Drug Sales in Volume by Country (2016-2021)
8.1.2 Latin America Immunology Drug Sales in Value by Country (2016-2021)
8.2 Latin America Immunology Drug Forecasted Market Size by Country
8.2.1 Latin America Immunology Drug Sales in Volume by Country (2022-2027)
8.2.2 Latin America Immunology Drug Sales in Value by Country (2022-2027)

9 Middle East and Africa Immunology Drug by Country
9.1 Middle East and Africa Immunology Drug Historic Market Size by Country
9.1.1 Middle East and Africa Immunology Drug Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Immunology Drug Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Immunology Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Immunology Drug Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Immunology Drug Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Immunology Drug Business
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Corporation Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Abbott Laboratories Immunology Drug Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Active Biotech
10.2.1 Active Biotech Corporation Information
10.2.2 Active Biotech Introduction and Business Overview
10.2.3 Active Biotech Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Abbott Laboratories Immunology Drug Products Offered
10.2.5 Active Biotech Recent Development
10.3 Eli Lilly and Company
10.3.1 Eli Lilly and Company Corporation Information
10.3.2 Eli Lilly and Company Introduction and Business Overview
10.3.3 Eli Lilly and Company Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Eli Lilly and Company Immunology Drug Products Offered
10.3.5 Eli Lilly and Company Recent Development
10.4 Autoimmune Inc.
10.4.1 Autoimmune Inc. Corporation Information
10.4.2 Autoimmune Inc. Introduction and Business Overview
10.4.3 Autoimmune Inc. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Autoimmune Inc. Immunology Drug Products Offered
10.4.5 Autoimmune Inc. Recent Development
10.5 Pfizer
10.5.1 Pfizer Corporation Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.5.4 Pfizer Immunology Drug Products Offered
10.5.5 Pfizer Recent Development
10.6 GlaxoSmithKline plc
10.6.1 GlaxoSmithKline plc Corporation Information
10.6.2 GlaxoSmithKline plc Introduction and Business Overview
10.6.3 GlaxoSmithKline plc Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.6.4 GlaxoSmithKline plc Immunology Drug Products Offered
10.6.5 GlaxoSmithKline plc Recent Development
10.7 Seattle Genetics
10.7.1 Seattle Genetics Corporation Information
10.7.2 Seattle Genetics Introduction and Business Overview
10.7.3 Seattle Genetics Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Seattle Genetics Immunology Drug Products Offered
10.7.5 Seattle Genetics Recent Development
10.8 Genentech
10.8.1 Genentech Corporation Information
10.8.2 Genentech Introduction and Business Overview
10.8.3 Genentech Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Genentech Immunology Drug Products Offered
10.8.5 Genentech Recent Development
10.9 F. Hoffmann-La Roche Ltd.
10.9.1 F. Hoffmann-La Roche Ltd. Corporation Information
10.9.2 F. Hoffmann-La Roche Ltd. Introduction and Business Overview
10.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Products Offered
10.9.5 F. Hoffmann-La Roche Ltd. Recent Development
10.10 Eisai Co.
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Immunology Drug Product Category, Application and Specification
10.10.3 Eisai Co. Immunology Drug Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Eisai Co. Recent Development
10.11 Bayer AG
10.11.1 Bayer AG Corporation Information
10.11.2 Bayer AG Introduction and Business Overview
10.11.3 Bayer AG Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Bayer AG Immunology Drug Products Offered
10.11.5 Bayer AG Recent Development
10.12 Sanofi Aventis LLC.
10.12.1 Sanofi Aventis LLC. Corporation Information
10.12.2 Sanofi Aventis LLC. Introduction and Business Overview
10.12.3 Sanofi Aventis LLC. Immunology Drug Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Sanofi Aventis LLC. Immunology Drug Products Offered
10.12.5 Sanofi Aventis LLC. Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Immunology Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Immunology Drug Industrial Chain Analysis
11.4 Immunology Drug Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Immunology Drug Distributors
12.3 Immunology Drug Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

THE FINAL REPORT WILL COVER THE IMPACT ANALYSIS OF COVID-19, DOWNLOAD FULL STUDY REPORT@ https://www.amecoresearch.com/buy/271234

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom
Contact: (+44) 2032861546

ABOUT US
The complete information about our alliance publishers and the business verticals they cater to helps us in appropriately responding to our client requirements and identifying the potential opportunities in the market and suggest the research that can best suit client's requirement. Our comprehensive list of research reports boasts a complete collection of database casing almost every market category and sub-category.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunology Drug Market Size, Growth and Forecast 2021 to 2028 By Ameco Research here

News-ID: 2368517 • Views: 149

More Releases from Ameco Research

G-CSF and G-CSF Biosimilars Market Size, Growth and Forecast 2021 to 2028 By Ame …
The worldwide G-CSF and G-CSF Biosimilars market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner
Animal Health Products Market Size, Growth and Forecast 2021 to 2028 By Ameco Re …
The worldwide Animal Health Products market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner rather
MRI Contrast Media Market Size, Share and Forecast 2021- 2028 By Ameco Research
The worldwide MRI Contrast Media market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner rather
Multiple Sclerosis Therapeutics Market Size, Share and Forecast 2021- 2028 By Am …
The worldwide Multiple Sclerosis Therapeutics market report is the very much investigated answer for the chiefs and academicians who are looking for a definite examination regarding both subjective just as quantitative, for the notable time frame and for the impending years gauge. The exploration report includes the business outline alongside the approaching dangers and supporting components that will drive or hamper the market development and give open doors sooner rather

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning